Study Finds Birth Hypoxia May Increase ADHD Likelihood
January 27, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
etanercept-ykro, Erelzi, Eticovo, Enbrel, etanercept-szzs,
Synonyms :
Class :
Antirheumatics snd TNF alfa inhibitors
Brand Name :
etanercept-ykro, Erelzi, Eticovo, Enbrel, etanercept-szzs,
Synonyms :
Class :
Antirheumatics snd TNF alfa inhibitors
Dosage Forms & Strengths:
Solution
25 mg/0.5 mL (0.5 mL)
Solution Auto-injector
50 mg/mL (Enbrel SureClick)
Solution Cartridge
50 mg/mL (Enbrel Mini)
Solution Prefilled Syringe
25 mg/0.5 mL (Enbrel)
50 mg/mL (Enbrel)
Solution Reconstituted
25 mg (Enbrel)
Dosage Forms & Strengths:
Solution
25 mg/0.5 mL (0.5 mL)
Solution Auto-injector
50 mg/mL (Enbrel SureClick)
Solution Cartridge
50 mg/mL (Enbrel Mini)
Solution Prefilled Syringe
25 mg/0.5 mL (Enbrel)
50 mg/mL (Enbrel)
Solution Reconstituted
25 mg (Enbrel)
coccidioides immitis skin test
it may reduce the diagnostic effect of coccidioides immitis skin test
it may reduce the therapeutic effect of covid-19 vaccine (subunit)
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
it may increase the immunosuppressive effect of abatacept
it may increase the immunosuppressive effect of immunosuppressants
it may increase the risk of adverse effects of anakinra
it may increase the immunosuppressive effect of anifrolumab
it may increase the immunosuppressive effect of baricitinib
it may increase the risk of adverse effects of bcg products
it may increase the immunosuppressive effect of biologic disease-modifying antirheumatic agents
biologic disease modifying antirheumatic drugs (dmards)
it may increase the immunosuppressive effect of other biologic disease-modifying antirheumatic drugs
It may enhance the immunosuppressive effects when combined with idecabtagene vicleucel
when etanercept is used in combination with diphtheria & tetanus toxoids, this leads to a reduction in the effects of diphtheria & tetanus toxoids through pharmacodynamic antagonism
when both drugs are combined, there may be an increased metabolism of etoposide
when both drugs are combined, the metabolism of paclitaxel increases when compared with etanercept
when both the drugs are combined, the metabolism of carmustine increases
When both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
interaction raises immunosuppressive effects and risk of infection
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of certolizumab pegol
may have an increased immunosuppressive effect when combined with anifrolumab
may have an increased immunosuppressive effect when combined with anti-psoriasis agents
the toxicity of either of the drugs is increased by immunosuppressive activity
respiratory syncytial virus vaccine, adjuvanted
may diminish the pharmacodynamic antagonistic effect of each other when combined
respiratory syncytial virus (RSV) vaccine
may diminish the pharmacodynamic antagonistic effect of each other when combined
may diminish the pharmacodynamic antagonistic effect of each other when combined
pneumococcal vaccine polyvalent
the activity of pneumococcal vaccine polyvalent is reduced due to pharmacodynamic antagonism
it may reduce the therapeutic effect of brincidofovir
immunosuppressants (therapeutic immunosuppressant agents) may enhance the immunosuppressive effect of cladribine. risk x: avoid combination
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Interleukins
It may enhance the risk of adverse effects when combined with Antipsoriatics drugs
When acetohexamide is used together with etanercept, this lead to rise in acetohexamide’s metabolism
When etanercept is used in combination with rabies vaccine, this leads to a reduction in the rabies vaccine effects through the process of pharmacodynamic antagonism
both the drugs increase the effect of immunosuppression risk of infection increases on administering both the drugs simultaneously
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
When etanercept is used together with lomitapide, this leads to an enhancement in lomitapide’s metabolism
Adverse drug reactions:
Frequency Defined
>10%
Diarrhea (16%)
Rash (13%)
Infection (81%)
Upper respiratory infections (65%)
Injection site reactions (43%)
Non-upper respiratory infections (54%)
1-10%
Urticaria (2%)
Hypersensitivity (1%)
Pruritus (5%)
Pyrexia (2%)
Post marketing Reports
Pancytopenia
Leukopenia
Neutropenia
Thrombocytopenia
Lymphadenopathy
aplastic anemia
Congestive heart failure
Inflammatory bowel disease (IBD
Angioedema
Pregnancy warnings:
Pregnancy Category: N/A
Lactation: known
Pregnancy Categories:
Patient Information Leaflet
Generic Name: etanercept (Rx)
Why do we use etanercept (Rx)?
etanercept (Rx) belongs to the class of Antirheumatics, TNF alfa inhibitors which helps to treat plaque psoriasis, Alzheimer’s disease, and joint damage in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
